Breaking News
Get 40% Off 0
🔎 See NVDA's full ProTips for an instant risks or rewards Claim 40% OFF
Close

Merck KGaA (MRCG)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
155.90 0.00    0.00%
19/02 - Real-time Data. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Italy
ISIN:  DE0006599905 
  • Volume: 0
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 154.10 - 155.90
Merck 155.90 0.00 0.00%

Merck KGaA Company Profile

 
Get an in-depth profile of Merck KGaA, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

63712

Equity Type

ORD

Merck KGaA operates as a science and technology company in Germany. The company’s Life Science segment offers a range of products, including reagents, consumable, devices, instruments, software, and services for scientific discovery, as well as provides lab water instruments, consumables and services, microbiology and biomonitoring, products, test assays, analytical reagents, and flow cytometry kits and instruments for pharma and biotech, industrial and testing, academics and government, and diagnostic sectors. Its Healthcare segment designs and develops medicines and intelligent devices for treatment of various therapeutics, such as oncology, neurology and immunology, endocrinology, and general medicines. The company’s Electronic segment provides semiconductor solutions, such as semiconductor materials, delivery systems and services, and intermolecular services for semiconductor and polymer removal chemistries applications; and display solutions comprising liquid crystals, OLED and quantum materials, reactive mesogens, photoresist materials, smart antenna, and dynamic liquid crystal glazing products, as well as offers liviFlex, a flexible platform, which offers a range of display materials. This segment also provides surface solution, such as cosmetics, effect pigments, and functional solutions; architecture solutions, including switchable windows; and automotive solutions. In addition, it has strategic alliances with Pfizer Inc. and GlaxoSmihKline plc to develop and commercialize active ingredients in immune-oncology; in-licensing agreement with Debiopharm International SA for developing drug candidates for the treatment of head and neck cancer; and out-licensing agreement with MoonLake Immunotherapeutics AG for developing a drug candidate for the treatment of inflammatory diseases. The company was founded in 1668 and is headquartered in Darmstadt, Germany. Merck KGaA operates as a subsidiary of E. Merck KG.

Contact Information

Address Frankfurter Strasse 250
Darmstadt, 64293
Germany
Phone 49 6151 72 0
Fax 49 6151 72 2000

Top Executives

Name Age Since Title
Gabriele Eismann 63 2014 Independent Member of Supervisory Board
Jürgen Glaser 62 2019 Independent Member of Supervisory Board
Helga Rübsamen-Schaeff 75 2014 Independent Member of Supervisory Board
Alexander Putz 58 2020 Member of Supervisory Board
Peter Emanuel Merck - 2019 Independent Member of Supervisory Board
Daniel Thelen - 2019 Independent Member of Supervisory Board
Dietmar Oeter 58 2014 Independent Member of Supervisory Board
Simon Thelen - 2019 Independent Member of Supervisory Board
Anne Lange - 2019 Independent Member of Supervisory Board
Michael Kleinemeier 66 2019 Independent Chairman of Supervisory Board
Christian Raabe - 2019 Independent Member of Supervisory Board
Renate Koehler - 2019 Independent Member of Supervisory Board
Birgit Biermann 51 2022 Member of Supervisory Board
Sascha Held 42 2019 Vice Chair of Supervisory Board
Barbara Lambert 62 2023 Member of Supervisory Board
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

MRCG Comments

Write your thoughts about Merck KGaA
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Chemsedine Bendaci
Chemsedine Bendaci Jan 12, 2022 7:49AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
target price 270€ according to zone bourse
Chemsedine Bendaci
Chemsedine Bendaci Jan 09, 2022 5:09AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
New pills against COVID-19
Päivi Saarela
Päivi Saarela Mar 02, 2021 8:28AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
BREAKING: President Biden will announce Tuesday that pharmaceutical giant Merck will help make JohnsonandJohnson’s single-shot coronavirus vaccine.
Raoul Petersen
Raoul Petersen May 04, 2019 2:45AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Short Merck enter now stop loss 98.50 take profit, take profit 86 per 10 cfd
Kishan Kshatriya
Kishan Kshatriya Sep 06, 2018 1:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy it Target 5000/-
Kishan Kshatriya
Kishan Kshatriya Sep 06, 2018 1:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy it Target 5000/-
Jagadish Gundu
Jagadish Gundu Sep 06, 2018 12:20AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
best price to buy ?
Narayan Patel
Narayan Patel Aug 07, 2018 6:51AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Target 4250/-
Forex Signals
Forex Signals Jan 16, 2016 1:01AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
downtrend triangle at 74
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email